Validation study to identify quality parameters of a proficiency training in nerve-sparing robotic-assisted radical prostatectomy

• Conditions: C61; Malignant neoplasm of prostate

• Registration Number: DRKS00024396
• Lead Sponsor: Martini-Klinik am UKE GmbH

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-02-09
• Study Completion: 2021-10-29
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: Male
• Target Recruitment: 100

Inclusion Criteria

EPIC-26 Sexuality Subscore >72
Bilateral Nerve-sparing
Tumorstage <pT3

Exclusion Criteria

EPIC-26 Sexuality Subscore <72
no/unilateral Nerve-sparing
Tumorstage >T2c

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Estimation for the recovery of erectile function by using EPIC 26 after 6 and 12 months.

Secondary Outcome Measures

Name	Time	Method
none was named